Last update 08 May 2025

Changsha Kinetic Energy Biotechnology Co., Ltd.

Dissolved
| Private Company|2003|Hunan Sheng, China

Overview

Tags

Nervous System Diseases
Cardiovascular Diseases
Herbal medicine

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Nervous System Diseases1
Top 5 Drug TypeCount
Herbal medicine1

Related

1
Drugs associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
Xingnao Shuluo Tablets
Target-
Mechanism-
Active Org.
Changsha Kinetic Energy Biotechnology Co., Ltd.
Originator Org.
Changsha Kinetic Energy Biotechnology Co., Ltd.
Active Indication
Brain Infarction [+1]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
CTR20132898
/ RecruitingPhase 2
治疗脑梗死（中风恢复期·瘀血阻络证）随机、双盲双模拟、阳性药/安慰剂平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, double-dummy, active drug/placebo parallel controlled, multicenter phase II clinical trial for the treatment of cerebral infarction (stroke recovery period, blood stasis obstruction syndrome)
100 Clinical Results associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Changsha Kinetic Energy Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 08 Dec 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Xingnao Shuluo Tablets
Ischemic stroke
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free